Clinical Trials Browser

Phase 2 × Mastocytosis, Systemic × midostaurin × Clear all

NCT00782067 2018-11-15

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Phase 2 Completed

116 enrolled 16 charts

LymphoidMyeloidOther hematologic neoplasm

Aggression, Leukemia, Leukemia, Mast-Cell, Mastocytosis, Systemic

NCT01920204 2015-01-19

Midostaurin in Indolent Systemic Mastocytosis

Phase 2 Unknown

Mastocytosis, Mastocytosis, Systemic